Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
264 Leser
Artikel bewerten:
(1)

Promptly Acquires the Software Solutions of MDprospects and Patient Spectrum, Significantly Expanding Its All-in-One Practice Management Platform and Revolutionizing Patient Experience

MIAMI, FLORIDA / ACCESS Newswire / April 22, 2025 / Promptly, the leading All-in-One Patient Experience Suite, today announced the strategic acquisition of MDprospects and Patient Spectrum, which includes MDprospects, MDidentity, Referify, and Appointec. This acquisition dramatically enhances Promptly's capabilities while supercharging practice management systems by streamlining repetitive tasks and significantly improving patient interactions for all stakeholders.

MDprospects is a premier web-based Customer Relationship Management (CRM) and lead management software specifically tailored for medical practices. An innovator since 2007, MDprospects was among the first CRM platforms to bring web-based efficiency to specialty medical practices. Initially designed as a lead tracking system to guide patient prospects through their journey from initial contact to consultation and then to treatment, it has evolved to include robust CRM functionalities such as targeted drip campaigns, advanced marketing tools, and text messaging capabilities. It empowers providers to efficiently manage patient inquiries, track leads, and optimize conversion rates, driving substantial revenue growth.

The Patient Spectrum ecosystem includes three specialized tools: MDidentity initiates patient reviews through email or text messages and provides reputation management with a customizable dashboard, seamless integrations, and automation. Referify streamlines referral management and mapping outreach, automating workflows that make tracking referral sources, events, and tasks easy for anyone managing relationships within a referral network, making it a powerful tool for physician liaisons. Appointec optimizes appointment scheduling with online booking, no-show reduction, and schedule optimization, improving efficiency for all providers within a practice and enhancing patient satisfaction.

"Bringing the innovative applications and platforms from MDprospects and Patient Spectrum into the Promptly family is a major win for everyone," said Dr. Anish Kapur, Founder and CEO of Promptly. "These platforms are not just exceptional software solutions; they are unique market offerings backed by teams deeply committed to their clients. Together, they form a powerhouse for lead management, fostering strong relationships with referring providers and generating positive online reviews that amplify practice visibility. By integrating their incredible toolsets and industry insights with Promptly's comprehensive suite of patient experience solutions, we deliver precisely what our clients have been asking for. Furthermore, pairing these platforms with Promptly's advancing AI capabilities marks the future of intelligent practice management."

Promptly's acquisitions of MDprospects, MDidentity, Referify, and Appointec are pivotal steps in its mission to create the ultimate all-in-one platform for exceptional patient experiences.

"As MDprospects, MDidentity, Referify, and Appointec are seamlessly integrated into the Promptly suite, the value of having these powerful tools under one roof will be tremendous," explained Michelle Pelletier, Promptly's Director of Product Experience and former CEO of MDprospects. This strategic move significantly enhances the patient experience, reduces practices' operational costs, increases revenue, and provides a superior software experience by eliminating the need for users to navigate multiple disparate systems.

With these acquisitions, Promptly continues to redefine the boundaries of patient engagement and practice operations. By uniting MDprospects, MDidentity, Referify, and Appointec into its intuitive platform, the Promptly Patient Experience Suite continues to deliver a seamless, intelligent solution that optimizes workflows, boosts revenue, elevates the patient experience, and humanizes healthcare.

About Promptly

Promptly Technology, Inc. is a leading healthcare technology company whose flagship product, the Promptly Patient Experience Suite, is a comprehensive software platform designed for specialty medical and dental practices to drive patient engagement, automate workflows, and accelerate revenue growth. Promptly empowers practices and their patients to experience the benefits of modern technology while consolidating the multitude of disparate systems prevalent in the marketplace. For more information, visit www.promptlycheckin.com.

Contact:

Shaun Priest
Sr. Vice President, Growth
shaun.priest@promptlycheckin.com
770-310-6990

.

SOURCE: Promptly



© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.